Online pharmacies will now have to employ strict investigation to prevent those who already have a healthy weight or have a history of eating weight loss disorders.

They will no longer be able to remove the drug, sold under brand names such as Vagovi and Mounzaro, who have just completed the online questionnaire or photo sent.

Along with the information of GP or medical records, in-practice or video consultation will be required to verify the patient body mass index (BMI).

The General Pharmaceutical Council says that failing to follow this new guidance may lead to enforcement action, including conditions such as fitness-to-practice check or inspection, and improvement schemes.

Gphc is concerned about both unprotected prescription and potential supply issues, some online pharmacies have set a target for allegedly processing a certain number of prescriptions per hour.

And the priscrebers will be asked to share “actively” with a patient’s GP information about what they are distributing.

GPHC Chief Executive Officer Duncan Rudkin said: “We know that online pharmacy services can provide a very valuable service – but through our inspection and examination, we have seen that many cases of drugs are unfairly online online Supplies are being made and people have been put at risk. “

Weight -loss drugs are now classified as “high risk” drugs, requiring additional safety measures, and offered on NHS With very strict criteria,

Semaglutides and tirzepetides were first used to help regulate their blood-circulation levels to type 2 diabetic patients.

But in the last three to four years, they began to be determined as an ally of a weight loss, which led to a global deficiency and Fake product,

Both are self-influenced in the upper hand, thigh or abdomen as weekly injection through pre-filled pen.

And patients usually start at low doses, which gradually increase.

Drugs mimic intestinal hormones such as peptide -1 (GLP -1), which is released after eating and usually people feel full.

Tirzepatide (mounjaro) also affects the hormone (GIP), an insulinotropic polypeptide (GIP) dependent on glucose, which controls metabolism and helps to regulate energy balance.

First study in weight loss drugs They have found that they can significantly improve heart health, with heart attacks, strokes, heart failure and lower levels of high blood pressure.